165 related articles for article (PubMed ID: 23040257)
1. Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder.
Sadeghi S; Garcia JA
Semin Oncol; 2012 Oct; 39(5):608-14. PubMed ID: 23040257
[TBL] [Abstract][Full Text] [Related]
2. Urothelial cancers: using biology to improve outcomes.
Pezaro C; Liew MS; Davis ID
Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
[TBL] [Abstract][Full Text] [Related]
3. Targeted agents in second-line bladder cancer therapy.
Gerullis H; Otto T; Ecke TH
Anticancer Drugs; 2012 Nov; 23(10):1003-15. PubMed ID: 22914698
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology and targeted therapies for urothelial carcinoma.
Seront E; Machiels JP
Cancer Treat Rev; 2015 Apr; 41(4):341-53. PubMed ID: 25828962
[TBL] [Abstract][Full Text] [Related]
5. Systemic chemotherapy for urothelial transitional cell carcinoma: an overview of toxicity.
Moulder SL; Roth BJ
Semin Urol Oncol; 2001 Aug; 19(3):194-201. PubMed ID: 11561987
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer: translating molecular genetic insights into clinical practice.
Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in advanced urothelial carcinoma.
Verdoorn BP; Kessler ER; Flaig TW
Oncology (Williston Park); 2013 Mar; 27(3):219-26. PubMed ID: 23687793
[TBL] [Abstract][Full Text] [Related]
8. Systemic chemotherapy for urothelial cancer.
Sonpavde G; Hutson TE; Berry WR
Clin Genitourin Cancer; 2006 Jun; 5(1):34-42. PubMed ID: 16859577
[TBL] [Abstract][Full Text] [Related]
9. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
Aparicio AM; Elkhouiery AB; Quinn DI
Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
[TBL] [Abstract][Full Text] [Related]
10. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
Pollera CF; Nelli F
Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
12. Overview of bladder cancer trials in the European Organization for Research and Treatment.
de Wit R;
Cancer; 2003 Apr; 97(8 Suppl):2120-6. PubMed ID: 12673705
[TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy for advanced bladder cancer: update and controversies.
Garcia JA; Dreicer R
J Clin Oncol; 2006 Dec; 24(35):5545-51. PubMed ID: 17158540
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.
Zachos I; Konstantinopoulos PA; Tzortzis V; Gravas S; Karatzas A; Karamouzis MV; Melekos M; Papavassiliou AG
Expert Opin Investig Drugs; 2010 Jul; 19(7):875-87. PubMed ID: 20528482
[TBL] [Abstract][Full Text] [Related]
15. Update on chemotherapy for advanced bladder cancer.
Rosenberg JE; Carroll PR; Small EJ
J Urol; 2005 Jul; 174(1):14-20. PubMed ID: 15947569
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic options for cisplatin-ineligible patients with advanced carcinoma of the urothelium.
Vaughn DJ
Cancer Treat Rev; 2008 Jun; 34(4):328-38. PubMed ID: 18262363
[TBL] [Abstract][Full Text] [Related]
17. Maintenance therapy for superficial bladder cancer.
Baselli EC; Greenberg RE
Oncology (Williston Park); 2001 Jan; 15(1):85-8; discussion 88-91. PubMed ID: 11271984
[TBL] [Abstract][Full Text] [Related]
18. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Rosenberg JE
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
20. Current status of chemotherapy for urothelial tract tumors.
Sternberg CN; Scher HI
Oncology (Williston Park); 1987 Jul; 1(5):41-50, 60. PubMed ID: 3079483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]